December 14, 2016
Baxter International Inc. and Hospira Inc. on Wednesday were again accused in Illinois federal court of conspiring to limit the amount of intravenous saline solution on the market and then hiking up prices, leaving hospitals scrambling to get their hands on enough of the vital substance.